M-CSF SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF

M-CSF-specific RXl-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in or remodeling in a subject afflicted with an osteoblastic or osteolytic...

Full description

Saved in:
Bibliographic Details
Main Authors SUNG, VICTORIA, AUCKERMAN, LEA, KAVANAUGH, WILLIAM, MICHAEL
Format Patent
LanguageEnglish
French
German
Published 04.03.2015
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:M-CSF-specific RXl-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in or remodeling in a subject afflicted with an osteoblastic or osteolytic disease.
Bibliography:Application Number: EP20060788709